-
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
(PAR-22-189)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): September 11, 2025
-
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (R24 Clinical Trials Not Allowed)
(PAR-22-190)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
National Institute of General Medical Sciences
Application Receipt Date(s): November 07, 2022
-
Postdoctoral Research Associate Training (PRAT) Program (Fi2)
(PAR-22-191)
National Institute of General Medical Sciences
Application Receipt Date(s): March 24, 2025
-
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
(PAR-22-192)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): September 11, 2025
-
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
(PAR-22-193)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): September 11, 2025
-
Point-of-Care Technologies Research Network: Technology Research and Development Centers (TRDC) (U54 Clinical Trial Optional)
(PAR-22-203)
National Institute of Biomedical Imaging and Bioengineering
National Institute of Allergy and Infectious Diseases
National Cancer Institute
National Institute on Drug Abuse
National Heart, Lung, and Blood Institute
John E. Fogarty International Center
National Center for Complementary and Integrative Health
Application Receipt Date(s): January 7, 2023
-
Research to Action: Assessing and Addressing Community Exposures to Environmental Contaminants (R01 Clinical Trial Optional)
(PAR-22-210)
National Institute of Environmental Health Sciences
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Multiple dates, see announcement.
-
Institutional Research and Academic Career Development Awards (IRACDA) (K12 - Independent Clinical Trial Not Allowed)
(PAR-22-212)
National Institute of General Medical Sciences
Application Receipt Date(s): October 3, 2024
-
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
(PAR-22-216)
National Cancer Institute
Application Receipt Date(s): July 1, 2025
-
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K01 - Clinical Trial Required)
(PAS-22-206)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute of Mental Health
National Center for Complementary and Integrative Health
Application Receipt Date(s): November 12, 2025
-
HEAL Initiative: Career Development Awards in Implementation Science for Substance Use Prevention and Treatment (K23 - Clinical Trial Required)
(PAS-22-207)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
National Cancer Institute
National Institute of Mental Health
National Center for Complementary and Integrative Health
Application Receipt Date(s): November 12, 2025
-
More Monitoring of Cognitive Change, Continued (M3C3) (U2C Clinical Trial Optional)
(RFA-AG-23-021)
National Institute on Aging
Application Receipt Date(s): October 20, 2022
-
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)
(RFA-AT-23-001)
National Center for Complementary and Integrative Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
Office of Research on Women's Health
Office of Behavioral and Social Sciences Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): November 21, 2022
-
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required)
(RFA-AT-23-002)
National Center for Complementary and Integrative Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Eye Institute
National Heart, Lung, and Blood Institute
National Institute of Nursing Research
National Center for Advancing Translational Sciences
Office of Research on Women's Health
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Application Receipt Date(s): November 21, 2022
-
Limited Competition: Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunologic Data Center (CIDC) (U24 Clinical Trial Not Allowed)
(RFA-CA-22-038)
National Cancer Institute
Application Receipt Date(s): Not Applicable
-
HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL) (R01 Clinical Trial Required)
(RFA-DA-23-041)
National Institute on Drug Abuse
National Institute on Aging
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
Application Receipt Date(s): September 27, 2022
-
HEAL Initiative: Multilevel Interventions to Reduce Harm and Improve Quality of Life for Patients on Long Term Opioid Therapy (MIRHIQL): Resource Center (U24- Clinical Trial Optional)
(RFA-DA-23-042)
National Institute on Drug Abuse
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Center for Complementary and Integrative Health
Application Receipt Date(s): September 27, 2022
-
HEAL Initiative: Preventing Opioid Misuse and Co-Occurring Conditions by Intervening on Social Determinants (R01 - Clinical Trials Optional)
(RFA-DA-23-051)
National Institute on Drug Abuse
National Institute on Aging
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Center for Complementary and Integrative Health
Office of Disease Prevention
Application Receipt Date(s): February 2, 2023
-
Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes (T1D) Research (U01 Clinical Trial Not Allowed)
(RFA-DK-21-031)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): October 26, 2022
-
Human Islet Research Network - Consortium on Targeting and Regeneration (HIRN-CTAR) (U01 Clinical Trial Not Allowed)
(RFA-DK-22-009)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): October 26, 2022
-
Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
(RFA-DK-22-010)
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 26, 2022
-
Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
(RFA-DK-22-016)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): December 20, 2022
-
Collaborative Research Using Biosamples from Type 1 Diabetes Clinical Studies (R01 - Clinical Trial Not Allowed)
(RFA-DK-22-021)
National Institute of Diabetes and Digestive and Kidney Diseases
Application Receipt Date(s): October 26, 2023
-
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Clinical Coordinating Centers (U01 Clinical Trial Not Allowed)
(RFA-DK-22-504)
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Not Applicable
-
Limited Competition for Continuation of the Prospective Study of Chronic Kidney Disease in Children Data Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-DK-22-505)
National Institute of Diabetes and Digestive and Kidney Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Heart, Lung, and Blood Institute
Application Receipt Date(s): Not Applicable
-
BRAIN Initiative: Transformative Brain Non-invasive Imaging Technology Development (UG3/UH3 Clinical Trial Not Allowed)
(RFA-EB-22-001)
National Institute of Biomedical Imaging and Bioengineering
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
National Center for Complementary and Integrative Health
Application Receipt Date(s): Multiple dates, see announcement.
-
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R01 Clinical Trial Not Allowed)
(RFA-MH-22-280)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): December 5, 2022
-
Epigenetic Mechanisms Regulating HIV CNS Latency and Neuropathogenesis Using Novel Single Cell Technologies (R21 Clinical Trial Not Allowed)
(RFA-MH-22-281)
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): December 5, 2022
-
Galvanizing Health Equity Through Novel and Diverse Educational Resources (GENDER) Research Education R25 (R25 Clinical Trial Not Allowed)
(RFA-OD-22-015)
Office of Research on Women's Health
National Institute on Aging
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Library of Medicine
Office of Behavioral and Social Sciences Research
Office of AIDS Research
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): January 7, 2023
-
Basket Clinical Trials of Drugs Targeting Shared Molecular Etiologies in Multiple Rare Diseases (U44 Clinical Trial Required)
(RFA-TR-22-029)
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): July 12, 2023